CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be participating in the RBC Capital Markets 2008 Healthcare Conference. Dan Passeri, Curis’ President and Chief Executive Officer, will participate in a panel entitled “Building A Pipeline Of Partnered And Proprietary Drugs” on Thursday, December 11, 2008 from 10:00 a.m. until 10:55 a.m. EST at the Westin Times Square Hotel in New York, New York. The panel will be moderated by Jason Kantor, RBC Senior Biotechnology Analyst.
